Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Urologists should screen for mental health issues before and during finasteride treatment.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

CT scans can find serious prostate cancer even when PSA levels are low.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Finasteride improves prostate cancer detection in PSA test.